ATED Therapeutics Ltd., 2026-04-02
An SEC Form D private-offering notice from Greenwich, CT, a $670,000 filer-stated offering target in Biotech. Filed 2026-04-02. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Develops a rapid blood based diagnostic test and therapeutics for Parkinson's disease and other central nervous system conditions.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Plasmonic Reactor Systems, Inc., 2026-04-08, $100K, Storrs, CT
- Tempest Therapeutics, Inc., 2026-04-03, $2M, Brisbane, CA
- Elidah, Inc., 2026-04-06, $2.5M, Newtown, CT
- Bascule Biosciences, Inc., 2026-04-02, $250K, New Rochelle, NY
- Algaenite, Inc., 2026-04-03, $2.5M, Guilford, CT
- Lifeward Ltd., 2026-04-02, Hudson, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.